Trans fatty acids: Induction of a pro-inflammatory phenotype in endothelial cells

Lipids

Volumn 47, Issue 7, 2012, Pages 647-657

  Harvey, Kevin A ^a   Walker, Candace L ^a   Xu, Zhidong ^a   Whitley, Phillip ^a   Siddiqui, Rafat A ^b  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Endothelial cells; Inflammation; Lipid droplets; NF B; Trans fatty acids

Indexed keywords

ELAIDIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LINOELAIDIC ACID; MYRISTIC ACID; PALMITIC ACID; PHOSPHOLIPID; SATURATED FATTY ACID; STEARIC ACID; TRANS FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL MEMBRANE; CONCENTRATION RESPONSE; CYTOTOXICITY; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LIPID COMPOSITION; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

CELL MEMBRANE; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FATTY ACIDS; LINOLEIC ACID; OLEIC ACID; STEARIC ACIDS; TRANS FATTY ACIDS; TRIGLYCERIDES;

EID: 84863986200     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-012-3681-2     Document Type: Article

References (32)

1. Stender S, Astrup A, Dyerberg J (2008) Ruminant and industrially produced trans fatty acids: health aspects. Food Nutr Res 52. doi:10.3402/fnr.v52i0.1651
2. Jakobsen MU, Bysted A, Andersen NL, Heitmann BL, Hartkopp HB, Leth T, Overvad K, Dyerberg J (2006) Intake of ruminant trans fatty acids in the Danish population aged 1-80 years. Eur J Clin Nutr 60:312-318
3. Allison DB, Denke MA, Dietschy JM, Emken EA, Kris-Etherton P, Niclolosi RJ (1995) Trans fatty acids and coronary heart disease risk. Report of the expert panel on trans fatty acids and coronary heart disease. Am J Clin Nutr 62:655S-708S
4. Ratnayake WM, L'Abbe MR, Farnworth S, Dumais L, Gagnon C, Lampi B, Casey V, Mohottalage D, Rondeau I, Underhill L, Vigneault M, Lillycrop W, Meleta M, Wong LY, Ng T, Gao Y, Kwong K, Chalouh S, Pantazopoulos P, Gunaratna H, Rahardja A, Blagden R, Roscoe V, Krakalovich T, Neumann G, Lombaert GA (2009) Trans fatty acids: current contents in Canadian foods and estimated intake levels for the Canadian population. J AOAC Int 92:1258-1276
5. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH (1993) Intake of trans fatty acids and risk of coronary heart disease among women (see comment). Lancet 341:581-585
6. Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D, Virtamo J (1997) Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The alphatocopherol, beta-carotene cancer prevention study. Am J Epidemiol 145:876-887
7. Ascherio A (2004) Trans fatty acids and coronary heart disease. Harvard School of Public Health 1-8
8. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354:1601-1613
9. Jakobsen MU, Overvad K, Dyerberg J, Heitmann BL (2008) Intake of ruminant trans fatty acids and risk of coronary heart disease. Int J Epidemiol 37:173-182
10. Motard-Belanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, Couture P, Lamarche B (2008) Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 87:593-599
11. Mozaffarian D, Aro A, Willett WC (2009) Health effects of trans fatty acids: experimental and observational evidence. Eur J Clin Nutr 63(Suppl 2):S5-S21
12. Bendsen NT, Stender S, Szecsi PB, Pedersen SB, Basu S, Hellgren LI, Newman JW, Larsen TM, Haugaard SB, Astrup A (2011) Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J Lipid Res 52:1821-1828
13. Schaffer JE (2003) Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14:281-287
14. Unger RH (2002) Lipotoxic diseases. Annu Rev Med 53:319-336
15. Sheehan MT, Jensen MD (2000) Metabolic complications of obesity. Pathophysiologic considerations. Med Clin North Am 84:363-385
16. Eckel RH, Barouch WW, Ershow AG (2002) Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases working group on the pathophysiology of obesity-associated cardiovascular disease. Circulation 105:2923-2928
17. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Balter K, Fraser GE, Goldbourt U, Hallmans G, Knekt P, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A (2009) Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 89:1425-1432
18. Merchant AT, Kelemen LE, de Koning L, Lonn E, Vuksan V, Jacobs R, Davis B, Teo KK, Yusuf S, Anand SS (2008) Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis. Am J Clin Nutr 87:168-174
19. Lemaitre RN, King IB, Mozaffarian D, Sotoodehnia N, Rea TD, Kuller LH, Tracy RP, Siscovick DS (2006) Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Circulation 114:209-215
20. Harvey KA, Walker CL, Xu Z, Whitley P, Pavlina TM, Hise M, Zaloga GP, Siddiqui RA (2010) Oleic acid inhibits stearic acidinduced inhibition of cell growth and pro-inflammatory responses in human aortic endothelial cells. J Lipid Res 51:3470-3480
21. Harvey KA, Walker CL, Pavlina TM, Xu Z, Zaloga GP, Siddiqui RA (2010) Long-chain saturated fatty acids induce pro-inflammatory responses and impact endothelial cell growth. Clin Nutr 29:492-500
22. Roach C, Feller SE, Ward JA, Shaikh SR, Zerouga M, Stillwell W (2004) Comparison of cis and trans fatty acid containing phosphatidylcholines on membrane properties. Biochemistry 43:6344-6351
23. van Greevenbroek MM, Voorhout WF, Erkelens DW, van Meer G, de Bruin TW (1995) Palmitic acid and linoleic acid metabolism in Caco-2 cells: different triglyceride synthesis and lipoprotein secretion. J Lipid Res 36:13-24
24. Folch J, Lees M, Stanley G H S (1957) A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226:497-509
25. Harvey KA, Arnold T, Rasool T, Antalis C, Miller SJ, Siddiqui RA (2008) Trans fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 99:723-731
26. Siddiqui RA, Harvey KA, Ruzmetov N, Miller SJ, Zaloga GP (2009) n-3 fatty acids prevent whereas trans fatty acids induce vascular inflammation and sudden cardiac death. Br J Nutr 102:1811-1819
27. Sanadgol N, Mostafaie A, Bahrami G, Mansouri K, Ghanbari F, Bidmeshkipour A (2010) Elaidic acid sustains LPS and TNFalpha induced ICAM-1 and VCAM-I expression on human bone marrow endothelial cells (HBMEC). Clin Biochem 43:968-972
28. Rezamand P, McGuire MA (2011) Effects of trans fatty acids on markers of inflammation in bovine mammary epithelial cells. J Dairy Sci 94:316-320
29. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB (2005) Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135:562-566
30. Qiu B, Hu JN, Liu R, Fan YW, Li J, Li Y, Deng ZY (2011) The caspase pathway of elaidic acid (9t-C18:1)-induced apoptosis in human umbilical vein endothelial cells. Cell Biology International (in press)
31. Zapolska-Downar D, Kosmider A, Naruszewicz M (2005) Trans fatty acids induce apoptosis in human endothelial cells. J Physiol Pharmacol 56:611-625
32. Vesper HW, Kuiper HC, Mirel LB, Johnson CL, Pirkle JL (2012) Levels of plasma trans fatty acids in non-Hispanic white adults in the United States in 2000 and 2009. JAMA 307:562-563